Specific HIV Medication Interactions: General
- Drug Interaction Warning: Saquinavir/Ritonavir and Rifampin (Rifampicin, Rifadin, Rimactane, Rofact) (February 8, 2005)
To read PDF, click here.
From U.S. Food and Drug Administration
- Don't Combine Fosamprenavir and Lopinavir/Ritonavir (February/March 2005)
From TheBodyPRO.com
- Do Not Combine Reyataz and Prilosec: News Summary (December 31, 2004)
In AIDS Treatment News, from AIDS Treatment News
- Atazanavir, With or Without Ritonavir, Should Not Be Coadministered With Proton Pump Inhibitors (December 20, 2004)
From U.S. Food and Drug Administration
- Warning Against Using Erythromycin (Even Orally) While Using Protease Inhibitors or Certain Other Drugs (October 26, 2004)
A study finds an increased risk of sudden death from cardiac causes.
In AIDS Treatment News, from AIDS Treatment News
On TheBodyPRO.com
- ddI + Tenofovir Combination Linked to Higher Pancreatitis Risk (October 2004)
Quick recap of a report in The Lancet.
In HIV Treatment ALERTS!, from The Center for AIDS
- Interaction Reported Between Grapefruit Juice and Statins (October 2004)
This interaction may also worsen other interactions between statins and HIV medications.
In HIV Treatment ALERTS!, from The Center for AIDS
- News on Developing Drugs and Drug Interactions (September/October 2004)
Updates on tipranavir, GS 9005 and the interaction between ddI and tenofovir.
In GMHC Treatment Issues, from Gay Men's Health Crisis
On TheBodyPRO.com
- Genetics Influence Response to HAART and Incidence of Pancreatitis, Studies Show (August 3, 2004)
From aidsmap.com
- Non-Antiretroviral Medication-Related Adverse Events During Treatment of HIV-Related Infections and Complications (May 2004)
From HIV InSite
- Changes to Labeling for Desyrel (Trazodone Hydrochloride) Tablets (PDF) (May 2004)
A "Dear Healthcare Professional" letter on potential interactions between this antidepressant and CYP3A4 inhibitors such as indinavir and ritonavir.
From U.S. Food and Drug Administration
- Atazanavir (Reyataz): New Recommendations if Combined With Tenofovir (Viread) -- and Warning on Viagra, Cialis, and Levitra (March 26, 2004)
New warnings on drug-drug interactions are noted in the prescribing information for atazanavir.
In AIDS Treatment News, from AIDS Treatment News
- Atazanavir/Tenofovir Combo Should Be Boosted With Ritonavir (August 8, 2003)
From U.S. Food and Drug Administration
- HIV-Positive Man Dies of Kidney Failure and Lactic Acidosis Due to Tenofovir/ddI Interaction (April 8, 2003)
From aidsmap.com
- Herbs, Supplements and HIV: Drug Interactions (April 2003)
To read PDF, click here.
From Project Inform
- Tenofovir DF and Didanosine EC: Investigation of Pharmacokinetic Drug-Drug and Drug-Food Interactions (November 21, 2002)
In The 6th International Congress on Drug Therapy in HIV Infection, from TheBodyPRO.com
- Intracellular Metabolism of AZT Leads to the Production of Significant Levels of d4T Triphosphate in HIV Infected Patients (November 19, 2002)
In The 6th International Congress on Drug Therapy in HIV Infection, from TheBodyPRO.com
- Viread-Videx EC Drug Interactions -- What's a Person to Do? (Fall 2002)
To read PDF, click here.
In STEP Perspective, from Seattle Treatment Education Project
On TheBodyPRO.com
- New Safety Information -- Viread Co-Administration With Videx (September 30, 2002)
From U.S. Food and Drug Administration
- New Safety Information for Videx (Didanosine, ddI) Used With Ribavirin (September 25, 2002)
From U.S. Food and Drug Administration
- FDA Bits: 3TC, Amprenavir and Nandrolone (September 2002)
Once-a-day dosing for 3TC (Epivir) approved; new interaction warnings for amprenavir (Agenerase); nandrolone decanoate returns to the U.S. market.
In HIV Treatment ALERTS!, from The Center for AIDS
|
Advertisement
|
Email
Glossary
